Definitive Contract VA24412D0329
Award Date 10/1/12
Potential Completion Date 5/31/19
Potential Value $12M
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Fixed Price with Economic Price Adjustment
Place of Performance
Pittsburgh, PA 15220, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
2
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Health Agency awarded a Blanket Purchase Agreement (BPA) call order valued at $8,773.71 to The Republic of Korea National Red Cross, operating as Gyeonggi Blood Center Red Cross, for the procurement of blood products. This firm-fixed-price call is issued without a set-aside designation and is performance-based in South Korea, where the vendor's facilities are located. The award supports critical blood inventory requirements for Department of Defense medical operations, specifically...
- This contract was awarded by the Defense Health Agency to Terumo BCT Inc., a manufacturer of medical devices and provider of services related to blood and cell technologies. The contract is for the provision of supplies and blood products such as tubing sets, blood bag systems, and cell washing equipment used in apheresis, cell therapy, and transfusion medicine applications. The contract is a Blanket Purchase Agreement (BPA) Call with a Firm Fixed Price pricing type, has a potential value of...
- This is a delivery order issued under a pre-existing indefinite delivery contract (IDC) to Immucor Inc., a manufacturer of in vitro diagnostic products and blood banking supplies. The $134,083.53 firm-fixed-price contract was awarded by the Pacific Air Forces, a component of the U.S. Air Force, for the provision of "DRUGS AND BIOLOGICALS" with no set-aside designation. Immucor has a history of providing specialized reagents, blood analyzers, testing equipment, and related consumables...
- This contract awarded by the Defense Health Agency (DHA) to the Republic of Korea National Red Cross, operating as the Gyeonggi Blood Center Red Cross, is for the delivery of apheresis platelets (A-PLT) in 250 mL units. The contract is a Blanket Purchase Agreement (BPA) call with a firm-fixed-price pricing type, has no set-aside designation, and has an ultimate completion date of December 31, 2024. The ceiling value of this contract award is $8,954.05. The Gyeonggi Blood Center Red Cross, a...
- This is a firm-fixed-price contract awarded by the Defense Health Agency to the Republic of Korea National Red Cross, doing business as the Gyeonggi Blood Center Red Cross, for the delivery of apheresis platelets, whole blood units, and other blood products. The contract is a Blanket Purchase Agreement (BPA) call with a potential value of $10,000.00 covering the period from April 1, 2023 to June 30, 2023. The agency has utilized this five-year, $249,000 BPA awarded in July 2022 to obtain vital...
- The Defense Health Agency awarded a Firm Fixed Price Blanket Purchase Agreement (BPA) call to The Republic of Korea National Red Cross, operating as Gyeonggi Blood Center Red Cross, for the provision of blood products. This contract call, valued at $8,910.38, was awarded on April 1, 2026, with a completion date of June 30, 2026. Performance will occur entirely at the contractor's facility in Suwon, Gyeonggi-do, South Korea. No set-aside designation was used for this award. The blood products...
- The Department of Veterans Affairs' Veterans Integrated Service Network 8 (VISN 8) awarded a delivery order valued at $938,573.86 to Oneblood, Inc. for the provision of Orlando blood and whole blood products. The award, issued on March 1, 2026, with an ultimate completion date of September 30, 2026, operates under a firm fixed-price contract structure with no socioeconomic set-aside designation. Oneblood, Inc., a non-profit community blood bank headquartered in Orlando, Florida, serves as a...
- This federal contract award, number SPE2DP24P0460, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Fenwal, Inc., a subsidiary of Fresenius Kabi that specializes in blood collection, separation, storage, and transfusion products and services. The $10,300.80 firm-fixed-price purchase order is for the delivery of washing solution, which is likely to support transfusion medicine and cell therapy applications for the Department of Defense and other federal agencies....
- This is a $162,312 Firm Fixed Price federal contract award from the Department of Veterans Affairs Veterans Health Administration to The Blood Center, a non-profit organization that provides blood and blood products. The contract is for the delivery of blood and blood products to support Veteran healthcare facilities in the VISN 16 region, which covers Southern Louisiana and Southern Mississippi. The contract does not have a set-aside designation. In addition to this contract, The Blood Center...
- This federal contract award was made by the Department of Veterans Affairs Veterans Health Administration to Fenwal, Inc., a Fresenius Kabi company that specializes in blood collection, separation, storage, and transfusion products and services. The contract, valued at $181,396.80, is for the delivery of Glycerolyte 57% glass bottles and Military Quad BPum PL 1240 450 CPDA1 blood bags. These products support the military's frozen blood program and are used by various federal agencies,...
OTHER FUNCTIONS: BLOOD AND BLOOD PRODUCT
Posted 10/1/12
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Blood and Blood Products for VA Pittsburgh Healthcare System | VA24411RP0754 | Department of Veterans Affairs | Award Notice 1/1 | 10/5/11, 9:27 AM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00007 | Funding Only Action | ($405k) | 5/14/19 | |
| P00004 | Funding Only Action | $125.7k | 2/11/16 | |
| P00005 | Exercise an Option | $1.0m | 11/1/15 | |
| P00003 | Exercise an Option | $1.0m | 11/1/14 | |
| P00002 | Change Order | $1.0m | 11/1/13 |